Polypoid anal melanoma. A case report and review of the literature

Annali Italiani di Chirurgia

Volumn 87, Issue 5, 2016, Pages 1-6

  Tutino, Roberta ^a,b   Clerico, Giuseppe ^b   Luc, Alberto Realis ^b   Gallo, Gaetano ^b,c   Trompetto, Mario ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b Policlinico di Monza   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Ano rectal melanoma; Mucosal melanoma; Rectal bleeding

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL SURGERY; ADJUVANT CHEMOTHERAPY; ANUS NEOPLASMS; CASE REPORT; COMPLICATION; DIFFERENTIAL DIAGNOSIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMORRHOIDS; HUMAN; MELANOMA; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PSYCHOLOGY; RECTAL DISEASES; TREATMENT REFUSAL; TUMOR INVASION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DIAGNOSIS, DIFFERENTIAL; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMORRHOIDS; HUMANS; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RECTAL DISEASES; TREATMENT REFUSAL;

EID: 84999025000     PISSN: 0003469X     EISSN: 2239253X     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Miller DM, Flaherty KT, Tsao H: Current status and future directions of molecularly targeted therapies and immunotherapies for melanoma. Semin Cutan Med Surg, 2014; 33(2):60-7.
2. Chen H, Cai Y, Liu Y, et al: Incidence, surgical treatment, and prognosis of anorectal melanoma from 1973 to 2011: A populationbased seer analysis. Medicine, 2016; 95(7): e2770.
3. Trompetto M, Clerico G, Cocorullo GF, et al.: Evaluation and management of hemorrhoids: Italian society of colorectal surgery (SICCR) consensus statement. Tech Coloproctol, 2015; 19(10):567-75.
4. Cocorullo G, Tutino R, Falco N, et al: Rectal bleeding andprolaps. . not always benign diseases rather anal cancer. The importance of a correct decision making since primary care. G Chir, 2016; 37(3):133-135
5. Chiu S, Joseph K, Ghosh S, et al.: Reasons for delays in diagnosis of anal cancer and the effect on patient satisfaction. Can Fam Physician, 2015; 61(11): e509-e516.
6. Sartelli M, Abu-Zidan FM, Catena F, et al: Global validation of the WSES Sepsis Severity Score for patients with complicated intraabdominal infections: A prospective multicentre study (WISS Study). World J Emerg Surg, 2015; 10(1): 1
7. Bello DM, Smyth E, Perez D, et al.: Anal versus rectal melanoma: Does site of origin predict outcome? Dis Colon Rectum, 2013; 56(2): 150.
8. Morlino A, La Torre G, Vita G, Cammarota A, Ignomirelli O: Malignant rectal melanoma. Ann Ital Chir, 2015; pii: S2239253X1502349X.
9. Tacastacas JD, Bray J, Cohen YK, et al.: Update on primary mucosal melanoma. J Am Acad Dermatol, 2014; 71(2): 366-375.
10. Stefanou, AJ: Anorectal melanoma. Semin Colon Rectal Surg, 2015; 26(2): 91-95.
11. Chae WY, Lee JL, Cho DH, et al: Preliminary suggestion about staging of anorectal malignant melanoma may be used to predict prognosis. Cancer Res Treat, 2015; 48(1):240-49.
12. Park JH, Lee JR, Yoon HS, et al.: Primary anorectal malignant melanoma treated with endoscopic mucosal resection. Intest Res, 2015; 13(2):170-74.
13. Malik A, Hull TL, Floruta C: What is the best surgical treatment for anorectal melanoma? Int J Colorectal Dis, 2004; 19(2): 121-23.
14. Giaccaglia V, Antonelli MS, Chieco PA, et al.: Technical characteristics can make the difference in a surgical linear stapler. Or not? J Surg Res, 2015; 197(1): 101-06.
15. Sashiyama H, Takayama W, Miyazaki SI, et al.: The diagnostic value of endoscopic ultrasonography and magnetic resonance imaging for anorectal malignant melanoma: report of a case. Surg Today, 2003; 33(3):209-13.
16. Knowles J, Lynch AC, Warrier SK, et al.: A case series of anal melanoma including the results of treatment with Imatinib in selected patients. Colorectal Dis, 2015; doi:10.1111/codi.13209.
17. Yeh JJ, Shia J, Hwu WJ, et al.: The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg , 2006; 244(6):1012-17.
18. Belli F, Gallino GF, Vullo SL, et al: Melanoma of the anorectal region: the experience of the National Cancer Institute of Milano. Eur J Surg Oncol, 2009; 35(7):757-62.
19. Nilsson PJ & Ragnarsson Olding BK: Importance of clear resection margins in anorectal malignant melanoma. Br J Surg, 2010; 97(1):98-103.
20. Kiran RP, Rottoli M, Pokala N, Fazio VW: Long-term outcomes after local excision and radical surgery for anal melanoma: Data from a population database. Dis Colon Rectum, 2010; 53(4): 402-08.
21. Choi BM, Kim HR, Yun HR, et al.: Treatment outcomes of anorectal melanoma. J Korean Soc Coloproctol, 2011; 27(1): 27-30.
22. Weyandt GH & Becker JC: Prognostic factors and therapy for primary anorectal melanoma. Int J Colorectal Dis, 2006; 21(5):488-89.
23. Ballo MT, Gershenwald JE, Zagars GK, et al.: Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma. J Clin Oncol, 2002; 20(23):4555-558.
24. Tien HY, McMasters KM, Edwards MJ, Chao C: Sentinel lymph node metastasis in anal melanoma. Int J Gastrointest Cancer, 2002; 32(1):53-56.
25. Giudice G, Robusto F, Nacchiero E: The surgical treatment of a melanoma patient with macroscopic metastasis in peri and retrocaval lymph nodes and with a positive sentinel lymph node in the groin. Ann Ital Chir, EP 4 February 2016.
26. Olsha O, Mintz A, Gimon Z, et al.: Anal melanoma in the era of sentinel lymph node mapping: A diagnostic and therapeutic challenge. Tech Coloproctol, 2005; 9(1):60-62.
27. Kanaan Z, Mulhall A, Mahid S, et al.: A systematic review of prognosis and therapy of anal malignant melanoma: A plea for more precise reporting of location and thickness. Am Surg, 2012; 78(1):28-35.
28. Yeh JJ, Weiser MR, Shia J, Hwu WJ: Response of stage IV anal mucosal melanoma to chemotherapy. Lancet Oncol, 2005; 6(6): 438-39.
29. Kawano N, Tashiro M, Taguchi M, et al: Combined treatment with dacarbazine, nimustine, cisplatin, and tamoxifen plus interferon-beta in a patient with advanced anorectal malignant melanoma. Jpn J Gastroenterol, 2008; 105(11):1627-633.
30. Guercio G, Tutino R, Falco N, et al.: Solitary metastasis from melanoma causing bowel perforation. Ann Ital Chir, 2015; 86.
31. Quintás-Cardama A, Lazar AJ, Woodman SE, et al.: Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib. Nat Clin Pract Oncol, 2008; 5(12):737-70.
32. Satzger I, Küttler U, Völker B, et al.: Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy. Case report and review of the literature. Dermatology, 2009; 220(1): 77-81.
33. Antonescu CR, Busam KJ, Francone TD, et al.: L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition. Int J Cancer, 2007; 121(2):257-64.
34. Gupta R, Sharma SC & Bose SM: Adjuvant interstitial brachytherapy in a case of anorectal melanoma. Trop Gastroenterol, 1999; 21(2):86-87.
35. Ling TC, Slater JM, Senthil M, et.: Surgical and radiation therapy management of recurrent anal melanoma. J Gastrointest Oncol, 2014; 5(1):E7.